Application

19234245 · TREATMENT OF DYSTROPHINOPATHIES WITH MICRODYSTROPHIN GENE THERAPY CONSTRUCTS

Filed 2025-06-10 · Granted The official file ↗ · Art unit 1633 · Examiner Joel D Levin Typical · CPC A61K 48/0058 · REGENXBIO INC. · Ballard Spahr LLP FOR RegenXBio

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

5.5 mo

to disposition 13.7 mo

Statutes raised

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.